ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SKYA vs APYX // REVENUE GROWTH (YOY)

SkyAI Inc. (NASDAQ) VS. Apyx Medical Corporation (NASDAQ) • 15-METRIC TALLY: SKYA 3 — APYX 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SKYA VS. APYX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SKYA APYX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 62.50% -92.50 APYX /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -28.90% -6.10 APYX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.67% -8.04% -0.63 APYX /fcf-yield <GO>
Operating Margin -60.00% -12.20% -47.80 APYX /operating-margins <GO>
Net Profit Margin -60.00% -21.20% -38.80 APYX /net-margins <GO>
Revenue Growth (YoY) ACTIVE — 9.90% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 11.30 0.75 +10.55 SKYA /balance-sheet <GO>
Piotroski F-Score Quality 2/9 5/9 -3.00 APYX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 74.0 49.1 +24.85 SKYA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $126.7M $113.3M $13.4M SKYA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SKYA REV APYX REV SKYA GROSS % APYX GROSS % SKYA FCF APYX FCF
FY 2025 $204.1K $52.8M -50.0% 62.5% -$11.0M -$9.1M
FY 2024 $0 $48.1M — 61.0% -$4.5M -$18.8M
FY 2023 $0 $52.3M — — -$8.5M -$5.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SKYA // BETA —
APYX // BETA —